Latest 8-K filings

Tessera Defense and Homeland Security Inc. announced its 2027 revenue target of $14-$16 million and long-term targets through 2029, projecting significant growth driven by its integrated physical security platform.

Carnival Corporation announced record-breaking third quarter 2026 financial results, surpassing guidance with all-time high revenues, net yields, and net income, driven by strong demand and cost discipline.

Liminatus Pharma announced it has regained compliance with Nasdaq's minimum bid price rule following a reverse stock split and a period of sustained share price increase.

uniQure N.V. presented updated Phase I/II data for AMT-130 in Huntington's disease, showing continued slowing of disease progression at 48 months and strong results at 36 months, supporting regulatory submissions.

ONAR Holding Corporation announced the initial closing of a $15 million financing round, convertible to preferred equity upon a Nasdaq uplisting, to fund a significant acquisition and bolster working capital.

Capstone Holding Corp. announced it has retired approximately 85% of its original convertible note principal, reducing the outstanding balance to $1 million and fully retiring one of its two notes.

TMC the Metals Company Inc. announced the appointment of Liam Mallon, former President of ExxonMobil Upstream, to its Board of Directors, strengthening its expertise as it advances deep-sea mineral operations.

Moleculin Biotech has successfully closed enrollment for Part A of its pivotal Phase 2/3 MIRACLE trial for relapsed or refractory acute myeloid leukemia, maintaining its Q1 2027 data readout timeline.

OMNIQ Corp. announced two municipal agreements in Pennsylvania for its Q Shield Safe City platform, marking entry into a new state with a recurring revenue model.

Global Business Travel Group, Inc. (Amex GBT) announced the completion of its acquisition by Long Lake Management for approximately $6.3 billion, delisting from the NYSE to operate as a private entity.

CareCloud, Inc. announced the promotion of Bonnie Boyer to Chief Financial Officer, effective October 1, 2026, succeeding Norman Roth who will transition to Advisor to the CEO.

Host Digital Inc. CEO Harmol Samra issued a letter to shareholders detailing the company's new direction in data center development for AI and HPC following its recent merger and public listing.

Nauticus Robotics, Inc. has secured a waiver for a September 30, 2026, triggering event related to its Series C Convertible Preferred Stock, extending the waiver period to December 31, 2027.

Ensysce Biosciences, Inc. filed an amendment to its Series C Preferred Stock Certificate of Designation, removing a specific redemption clause.

OneMedNet Corporation is implementing a 1-for-10 reverse stock split to comply with Nasdaq's minimum bid price requirement and aims to broaden investor interest.

PRA Group announces a proposed $400 million offering of senior notes due 2033 to refinance existing credit facility borrowings.

NewAmsterdam Pharma has dosed the first participant in its Phase 2b SPINOZA clinical trial evaluating obicetrapib for preclinical Alzheimer's disease.

The PNC Financial Services Group, Inc. announced the redemption of $525 million in Depositary Shares representing interests in its Series S Preferred Stock.

Flash Sports & Media Holdings, Inc. has entered into a significant agreement with MindWave Innovations Inc. to develop and operate FlashChain, a blockchain network aimed at revolutionizing digital broadcasting rights, asset tracking, and fan engagement.

Alaska Air Group detailed its 'activation' phase of the Alaska Accelerate plan, focusing on premium experiences, global connectivity, loyalty, and cargo to drive future earnings.

Keros Therapeutics announced it will receive a $20 million development milestone payment from Takeda following the first patient dosing in the Phase 3 ELRiSE MF clinical trial for elritercept.

First United Corporation announced the election of Steven R. Stuck, Shawn Bender, and Nina Beitzel to its Board of Directors, effective September 24, 2026.

Top Financial Group Limited has amended appointment letters for its independent non-executive directors, shifting compensation from a mix of cash and shares to entirely cash-based.

Imunon, Inc. has entered into an Exchange Agreement to convert $1.2 million of its A-1 Note principal into Series B Preferred Stock, impacting its capital structure.

SurgePays, Inc. has received an additional 180-day extension from Nasdaq to regain compliance with the minimum $1.00 bid price requirement, now until March 22, 2027.

Bloomin Brands, Inc. has successfully amended and restated its revolving credit facility, extending the maturity date to September 25, 2031, while maintaining existing commitments and pricing.

Allarity Therapeutics announced the expansion of its in-house medical laboratory to include proteomics and cell line research, enhancing its capabilities for drug development and external partnerships.

Atossa Therapeutics announced a plan to issue contingent value rights (CVRs) to shareholders, entitling them to 25% of net proceeds from the monetization of a rare pediatric disease priority review voucher, up to a $50 million cap.

TransDigm Inc. has completed a $3 billion offering of 6.75% Senior Secured Notes due 2035, with proceeds intended for repurchasing existing debt and general corporate purposes.

Unicycive Therapeutics has resubmitted its New Drug Application for oxylanthanum carbonate, a phosphate binder for kidney disease patients, with an anticipated FDA decision within six months.